AlloVax
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AlloVax, covering 2020-01-23 to 2020-01-23. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Tolerability Study of AlloVax(TM) in Patients With Metastatic or Recurrent Cancer of the Head and Neck [Phase 2]